Discovery of Radioiodinated Monomeric Anthraquinones as a Novel Class of Necrosis Avid Agents for Early Imaging of Necrotic Myocardium

Scientific Reports
Qin WangZhiqi Yin

Abstract

Assessment of myocardial viability is deemed necessary to aid in clinical decision making whether to recommend revascularization therapy for patients with myocardial infarction (MI). Dianthraquinones such as hypericin (Hyp) selectively accumulate in necrotic myocardium, but were unsuitable for early imaging after administration to assess myocardial viability. Since dianthraquinones can be composed by coupling two molecules of monomeric anthraquinone and the active center can be found by splitting chemical structure, we propose that monomeric anthraquinones may be effective functional groups for necrosis targetability. In this study, eight radioiodinated monomeric anthraquinones were evaluated as novel necrosis avid agents (NAAs) for imaging of necrotic myocardium. All (131)I-anthraquinones showed high affinity to necrotic tissues and (131)I-rhein emerged as the most promising compound. Infarcts were visualized on SPECT/CT images at 6 h after injection of (131)I-rhein, which was earlier than that with (131)I-Hyp. Moreover, (131)I-rhein showed satisfactory heart-to-blood, heart-to-liver and heart-to-lung ratios for obtaining images of good diagnostic quality. (131)I-rhein was a more promising "hot spot imaging" tracer for earlier...Continue Reading

References

Aug 5, 1999·Seminars in Nuclear Medicine·B A Khaw
Dec 25, 2002·Journal of Ethnopharmacology·Je-Hyun LeeChungsook Kim
Mar 15, 2003·European Journal of Nuclear Medicine and Molecular Imaging·Albert Flotats, Ignasi Carrió
Feb 2, 2006·European Journal of Nuclear Medicine and Molecular Imaging·Yicheng NiGuy M Bormans
Mar 31, 2007·American Heart Journal·Harry R PhillipsJoseph Rogers
Jun 27, 2007·Radiology·Joseph C WuSanjiv S Gambhir
Apr 14, 2009·Methods : a Companion to Methods in Enzymology·Marijke De Saint-HubertFelix M Mottaghy
Jul 4, 2012·Journal of Separation Science·Hui SunXijun Wang
Sep 20, 2012·Bioconjugate Chemistry·Bryan A Smith, Bradley D Smith
May 1, 2013·Journal of Drug Targeting·Ming KongYicheng Ni
Sep 12, 2013·Journal of Controlled Release : Official Journal of the Controlled Release Society·Bodhraj AcharyaByung-Heon Lee
Dec 11, 2013·Basic Research in Cardiology·Naheed JivrajRené M Botnar
Feb 7, 2015·Journal of Drug Targeting·Xuejiao LiuJian Zhang
Feb 28, 2015·Current Medicinal Chemistry·Marlein Miranda ConaYicheng Ni

❮ Previous
Next ❯

Citations

Aug 3, 2016·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·Jamshid ShiraniVasken Dilsizian
Mar 13, 2018·Medicinal Research Reviews·Anna A RybczynskaAren van Waarde
Jan 7, 2018·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Qiaomei JinDongjian Zhang
Feb 11, 2020·Journal of Drug Targeting·Dongjian ZhangJian Zhang
Apr 22, 2020·Journal of Drug Targeting·Dongjian ZhangJian Zhang
May 7, 2020·The British Journal of Radiology·Chang Su, Yan Xu
May 5, 2017·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Chang SuZhiqi Yin
Jul 25, 2019·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Libang ZhangJian Zhang
Jun 30, 2019·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Aimi ZhangShaoli Song
Aug 17, 2019·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·Tianze WuZhiqi Yin
Mar 10, 2020·Bioconjugate Chemistry·Dongjian ZhangJian Zhang
Feb 16, 2017·ACS Medicinal Chemistry Letters·Ai-Yan JiZhi-Qi Yin

❮ Previous
Next ❯

Software Mentioned

Drug and Statistics
Astonish
Optiquant

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.